Giant Biogene Holding Co Ltd

02367

Company Profile

  • Business description

    Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

  • Contact

    No. 1855, Shanglin Yuan 7th Road
    Chang’an District
    Shaanxi Province
    Xi’an
    CHN

    http://www.xajuzi.com

  • Sector

    Consumer Defensive

    Stock type

    Defensive

  • Industry

    Household & Personal Products

    Fiscal Year End

    31 December 2025

    Employees

    2,162

Stocks News & Analysis

stocks

3 Warren Buffett stocks to avoid today

These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
stocks

Should you invest in small caps?

With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio. 
stocks

Strong second half anticipated for ASX mining play

A more focused business model should benefit the company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,079.2017.700.20%
CAC 407,870.6875.260.97%
DAX 4023,739.47204.640.87%
Dow JONES (US)46,247.29299.970.65%
FTSE 1009,284.8370.850.77%
HKSE26,128.20356.48-1.35%
NASDAQ22,484.0799.370.44%
Nikkei 22545,354.99399.94-0.87%
NZX 50 Index13,111.7342.06-0.32%
S&P 5006,643.7038.980.59%
S&P/ASX 2008,787.7013.200.15%
SSE Composite Index3,828.1125.20-0.65%

Market Movers